Loading stocks --
Market News
English اردو

BF Biosciences Limited FY26 Net Profit Surges 41% to Rs632.13m

BFBIO BF Biosciences Limited
Rs. 137.22 -0.74%
Stock ImpactStrong Positive

BF Biosciences Limited (PSX: BFBIO) reported a 41% surge in its net profit for the fiscal year ended June 30, 2026, reaching Rs632.13m compared to Rs447.15m in the preceding year.

Reflecting this performance, the basic and diluted earnings per share (EPS) rose to Rs7.16 from Rs5.52 in FY25. The strong growth was driven by top-line volume expansion and a substantial increase in gross margins.

MetricFY26 (Rs)FY25 (Rs)Change (%)
Net Revenue9,461,253,8025,837,466,16962.1%
Gross Profit4,087,705,1702,287,831,34978.7%
Net Profit632,127,122447,147,35641.4%
EPS (Rs)7.165.5229.7%

Net revenue grew by 62% year-on-year to Rs9.46bn, while finance costs decreased by 17% to Rs105.96m, providing debt-servicing relief. Overall, the company closed the fiscal year on a strong financial footing.

Read the full story on the original publisher’s website.

Open original article